Egalet Corp (EGLTQ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert Samuel Radie
Employees:
154
600 LEE ROAD, SUITE 100, WAYNE, PA, 19087
610-833-4200

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Egalet Corp. engages in developing and manufacturing pharmaceutical products. Its products include ARYMO, OXAYDO, and SPRIX Nasal Spray. The company was founded by Jean-Francois B. Formela in August 2013 and is headquartered in Wayne, PA.

Data derived from most recent annual or quarterly report
Market Cap 168.497 Thousand Shares Outstanding9.361 Million Avg 30-day Volume 628.301 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from EGLTQ instead.

View recent insider trading info

Funds Holding EGLTQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EGLTQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PHILLIPS GARY M.

  • Director
No longer subject to file 2020-05-20 0

WALBERT TIMOTHY P

  • Director
No longer subject to file 2020-05-20 0

SMITH TODD N PRESIDENT AND CEO

  • Officer
  • Director
0 2020-05-20 0

PAULS MATTHEW

  • Director
0 2020-05-20 0

MCINNIS JOE

  • Director
No longer subject to file 2020-05-20 0

STROBECK MARK CHIEF OPERATING OFFICER

  • Officer
No longer subject to file 2020-05-20 0

CR GROUP L.P.

CRG PARTNERS III - PARALLEL FUND B (CAYMAN) L.P.

CRG PARTNERS III - PARALLEL FUND (A) L.P.

CRG PARTNERS III (CAYMAN) LEV AIV I L.P.

CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.

CRG PARTNERS III L.P.

LOAN SECURITY HOLDINGS I LLC

  • 10% Owner
No longer subject to file 2020-05-20 0

SMILEY ANDREA HESLIN

  • Director
No longer subject to file 2020-05-20 0

TIMMINS MEGAN C. GENERAL COUNSEL

  • Officer
No longer subject to file 2020-05-20 0

RADIE ROBERT S PRINCIPAL FINANCIAL OFFICER

  • Officer
No longer subject to file 2019-12-31 0

RIVA RIDGE CAPITAL MANAGEMENT LP

RIVA RIDGE GP LLC

GOLDEN STEPHEN H

SHIM JAMES

  • GENERAL PARTNER OF RRCMMANAGING MEMBERMANAGING MEMBER
938,661 2019-12-23 0

WILKINS H JEFFREY SVP AND CHIEF MEDICAL OFFICER

  • Officer
190,000 2019-07-01 0

CAPITAL ROYALTY L.P.

IROKO PHARMACEUTICALS INC.

IROKO PROPERTIES INC.

CRG PARTNERS III (CAYMAN) LEV AIV I L.P.

CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.

CRG PARTNERS III L.P.

LOAN SECURITY HOLDINGS I LLC

CRG PARTNERS III - PARALLEL FUND B (CAYMAN) L.P.

CRG PARTNERS III - PARALLEL FUND (A) L.P.

  • 10% Owner
4,586,874 2019-06-28 0

DUSTER LUKE

  • Director
No longer subject to file 2019-06-18 0

SHEA PATRICK M CHIEF COMMERCIAL OFFICER

  • Officer
90,000 2019-03-26 0

OSBORN JOHN E

  • Director
No longer subject to file 2019-01-31 0

ROCHE ROBERT P JR

  • Director
No longer subject to file 2019-01-31 0

WEAVER GREGORY L

  • Director
No longer subject to file 2019-01-31 0

VARIAN JOHN

  • Director
No longer subject to file 2019-01-31 0

CAPITAL ROYALTY L.P.

CRG PARTNERS III - PARALLEL FUND B (CAYMAN) L.P.

CRG PARTNERS III - PARALLEL FUND (A) L.P.

IROKO PHARMACEUTICALS INC.

IROKO PROPERTIES INC.

CRG PARTNERS III (CAYMAN) LEV AIV I L.P.

CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.

CRG PARTNERS III L.P.

  • 10% Owner
4,586,874 2019-01-31 0

CARLIN BARBARA CHIEF ACCOUNTING OFFICER

  • Officer
0 2019-01-31 0

NICOLAIDES NICHOLAS C

  • Director
No longer subject to file 2019-01-31 0

HOCHBERG ELAINE

  • Director
No longer subject to file 2019-01-31 0

HOLMES TODD

  • Director
0 2019-01-31 0

MUSIAL STAN CHIEF FINANCIAL OFFICER

  • Officer
347,407 2018-06-13 0

VARKI PAUL SVP, GC & CHIEF COMPLIANCE OFF

  • Officer
29,514 2017-07-03 0

DAYNO JEFFREY M. CHIEF MEDICAL OFFICER

  • Officer
0 2017-06-08 0

MELLOY DEANNE F. CHIEF COMMERCIAL OFFICER

  • Officer
33,420 2016-04-05 0

LINDHARDT KARSTEN VP, RESEARCH & DEVELOPMENT

  • Officer
0 2016-01-04 0

FORMELA JEAN FRANCOIS

  • Director
  • 10% Owner
2,460,949 2014-02-11 0

ATLAS VENTURE FUND VII L P

  • 10% Owner
2,460,949 2014-02-11 0

INDEX VENTURE ASSOCIATES III LTD

INDEX VENTURES III (JERSEY) L.P.

INDEX VENTURES III (DELAWARE) L.P.

INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P.

YUCCA (JERSEY) SLP

INDEX VENTURES LIFE VI (JERSEY) L.P.

  • 10% Owner
1,016,577 2014-02-11 0

DANISH BIOTECH SPV I P/S

OMEGA FUND IV, L.P.

  • 10% Owner
629,306 2014-02-11 0

SUNSTONE LIFE SCIENCE VENTURES FUND II K/S

  • 10% Owner
2,014,553 2014-02-11 0

SEGERROS ANDREAS RUTGER

  • Director
  • 10% Owner
2,014,553 2014-02-11 0

AGUIAR-LUCANDER RENEE

  • Director
314,574 2014-02-11 0

KOZLOV ANDREY

  • Director
0 2014-02-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments